CVRx Inc
NASDAQ:CVRX
CVRx Inc
Cash from Financing Activities
CVRx Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
CVRx Inc
NASDAQ:CVRX
|
Cash from Financing Activities
$24m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Financing Activities
-$2.3B
|
CAGR 3-Years
-144%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-10%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Financing Activities
$1.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
Stryker Corp
NYSE:SYK
|
Cash from Financing Activities
-$1.5B
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-25%
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Financing Activities
-$6.9B
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Financing Activities
$46.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
See Also
What is CVRx Inc's Cash from Financing Activities?
Cash from Financing Activities
24m
USD
Based on the financial report for Dec 31, 2023, CVRx Inc's Cash from Financing Activities amounts to 24m USD.
What is CVRx Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-22%
Over the last year, the Cash from Financing Activities growth was 220%. The average annual Cash from Financing Activities growth rates for CVRx Inc have been -22% over the past three years .